Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial
Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with...
Gespeichert in:
Veröffentlicht in: | Fertility and sterility 2017-06, Vol.107 (6), p.1329-1335.e2 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1335.e2 |
---|---|
container_issue | 6 |
container_start_page | 1329 |
container_title | Fertility and sterility |
container_volume | 107 |
creator | Nandi, Anupa, M.R.C.O.G Bhide, Priya, M.R.C.O.G Hooper, Richard, Ph.D Gudi, Anil, M.R.C.O.G Shah, Amit, M.R.C.O.G Khan, Khalid, Ph.D Homburg, Roy, F.R.C.O.G |
description | Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382. |
doi_str_mv | 10.1016/j.fertnstert.2017.03.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1899114604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028217303035</els_id><sourcerecordid>1899114604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</originalsourceid><addsrcrecordid>eNqNUsuO1DAQjBCIHRZ-AfnIJcGO4zw4IMGKx0orcQDOlmN32B4ce7CdhdmfgW_hy3CUASROyJJfVdXddnVREEYrRln7dF9NEJKLKc9VTVlXUV7Rur9T7JgQbSlawe8WO0qZKPN1fVY8iHFPKW1ZV98vzupeUMZbtiu-X7oU1JIDoQOCLsKMTiX0jnzFdE0-eaeMT8Ef0JGYcF7shvqQ2T9_3GDGyFoNWrzdoClj6RpICqDSDC4RP5HFwbeDVTmLIXEZT4p0fEYUCcoZP-NthrTP9Xhr8zYFVPZhcW9SNsKj03pefHz96sPF2_Lq3ZvLixdXpW66IZWj6Ouegh5o0zA2iG4EUJzTgQkwnItBG-jadtRqrCfVdxNvFeuHfDCNqcXEz4snW9xD8F8WiEnOGDVYqxz4JcpMHhhrWtpkar9RdfAxBpjkIeCswlEyKld75F7-tUeu9kjKZfYhSx-fsizjDOaP8LcfmfByI0B-6w1CkFEjOA0GA-gkjcf_yfL8nyDaokOt7Gc4Qtz7Jbj8l5LJWEsq369tsnYJ6zjNQ_BfTbzCZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899114604</pqid></control><display><type>article</type><title>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Nandi, Anupa, M.R.C.O.G ; Bhide, Priya, M.R.C.O.G ; Hooper, Richard, Ph.D ; Gudi, Anil, M.R.C.O.G ; Shah, Amit, M.R.C.O.G ; Khan, Khalid, Ph.D ; Homburg, Roy, F.R.C.O.G</creator><creatorcontrib>Nandi, Anupa, M.R.C.O.G ; Bhide, Priya, M.R.C.O.G ; Hooper, Richard, Ph.D ; Gudi, Anil, M.R.C.O.G ; Shah, Amit, M.R.C.O.G ; Khan, Khalid, Ph.D ; Homburg, Roy, F.R.C.O.G</creatorcontrib><description>Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/j.fertnstert.2017.03.028</identifier><identifier>PMID: 28501361</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Combined Modality Therapy - methods ; Combined Modality Therapy - utilization ; Comorbidity ; Female ; Fertilization in Vitro - utilization ; Gonadotropins - administration & dosage ; Humans ; Infertility - diagnosis ; Infertility - therapy ; Insemination, Artificial - utilization ; Internal Medicine ; intrauterine insemination ; In vitro fertilization ; Male ; Obstetrics and Gynecology ; Ovarian Hyperstimulation Syndrome - epidemiology ; Ovarian Hyperstimulation Syndrome - prevention & control ; Ovulation Induction - utilization ; Pregnancy ; Pregnancy Outcome - epidemiology ; Pregnancy Rate ; Risk Factors ; Treatment Outcome ; unexplained infertility ; unexplained subfertility ; United Kingdom - epidemiology</subject><ispartof>Fertility and sterility, 2017-06, Vol.107 (6), p.1329-1335.e2</ispartof><rights>2017</rights><rights>Crown Copyright © 2017. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</citedby><cites>FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028217303035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28501361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nandi, Anupa, M.R.C.O.G</creatorcontrib><creatorcontrib>Bhide, Priya, M.R.C.O.G</creatorcontrib><creatorcontrib>Hooper, Richard, Ph.D</creatorcontrib><creatorcontrib>Gudi, Anil, M.R.C.O.G</creatorcontrib><creatorcontrib>Shah, Amit, M.R.C.O.G</creatorcontrib><creatorcontrib>Khan, Khalid, Ph.D</creatorcontrib><creatorcontrib>Homburg, Roy, F.R.C.O.G</creatorcontrib><title>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.</description><subject>Adult</subject><subject>Combined Modality Therapy - methods</subject><subject>Combined Modality Therapy - utilization</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Fertilization in Vitro - utilization</subject><subject>Gonadotropins - administration & dosage</subject><subject>Humans</subject><subject>Infertility - diagnosis</subject><subject>Infertility - therapy</subject><subject>Insemination, Artificial - utilization</subject><subject>Internal Medicine</subject><subject>intrauterine insemination</subject><subject>In vitro fertilization</subject><subject>Male</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian Hyperstimulation Syndrome - epidemiology</subject><subject>Ovarian Hyperstimulation Syndrome - prevention & control</subject><subject>Ovulation Induction - utilization</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome - epidemiology</subject><subject>Pregnancy Rate</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>unexplained infertility</subject><subject>unexplained subfertility</subject><subject>United Kingdom - epidemiology</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsuO1DAQjBCIHRZ-AfnIJcGO4zw4IMGKx0orcQDOlmN32B4ce7CdhdmfgW_hy3CUASROyJJfVdXddnVREEYrRln7dF9NEJKLKc9VTVlXUV7Rur9T7JgQbSlawe8WO0qZKPN1fVY8iHFPKW1ZV98vzupeUMZbtiu-X7oU1JIDoQOCLsKMTiX0jnzFdE0-eaeMT8Ef0JGYcF7shvqQ2T9_3GDGyFoNWrzdoClj6RpICqDSDC4RP5HFwbeDVTmLIXEZT4p0fEYUCcoZP-NthrTP9Xhr8zYFVPZhcW9SNsKj03pefHz96sPF2_Lq3ZvLixdXpW66IZWj6Ouegh5o0zA2iG4EUJzTgQkwnItBG-jadtRqrCfVdxNvFeuHfDCNqcXEz4snW9xD8F8WiEnOGDVYqxz4JcpMHhhrWtpkar9RdfAxBpjkIeCswlEyKld75F7-tUeu9kjKZfYhSx-fsizjDOaP8LcfmfByI0B-6w1CkFEjOA0GA-gkjcf_yfL8nyDaokOt7Gc4Qtz7Jbj8l5LJWEsq369tsnYJ6zjNQ_BfTbzCZQ</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Nandi, Anupa, M.R.C.O.G</creator><creator>Bhide, Priya, M.R.C.O.G</creator><creator>Hooper, Richard, Ph.D</creator><creator>Gudi, Anil, M.R.C.O.G</creator><creator>Shah, Amit, M.R.C.O.G</creator><creator>Khan, Khalid, Ph.D</creator><creator>Homburg, Roy, F.R.C.O.G</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</title><author>Nandi, Anupa, M.R.C.O.G ; Bhide, Priya, M.R.C.O.G ; Hooper, Richard, Ph.D ; Gudi, Anil, M.R.C.O.G ; Shah, Amit, M.R.C.O.G ; Khan, Khalid, Ph.D ; Homburg, Roy, F.R.C.O.G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Combined Modality Therapy - methods</topic><topic>Combined Modality Therapy - utilization</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Fertilization in Vitro - utilization</topic><topic>Gonadotropins - administration & dosage</topic><topic>Humans</topic><topic>Infertility - diagnosis</topic><topic>Infertility - therapy</topic><topic>Insemination, Artificial - utilization</topic><topic>Internal Medicine</topic><topic>intrauterine insemination</topic><topic>In vitro fertilization</topic><topic>Male</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian Hyperstimulation Syndrome - epidemiology</topic><topic>Ovarian Hyperstimulation Syndrome - prevention & control</topic><topic>Ovulation Induction - utilization</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome - epidemiology</topic><topic>Pregnancy Rate</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>unexplained infertility</topic><topic>unexplained subfertility</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nandi, Anupa, M.R.C.O.G</creatorcontrib><creatorcontrib>Bhide, Priya, M.R.C.O.G</creatorcontrib><creatorcontrib>Hooper, Richard, Ph.D</creatorcontrib><creatorcontrib>Gudi, Anil, M.R.C.O.G</creatorcontrib><creatorcontrib>Shah, Amit, M.R.C.O.G</creatorcontrib><creatorcontrib>Khan, Khalid, Ph.D</creatorcontrib><creatorcontrib>Homburg, Roy, F.R.C.O.G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nandi, Anupa, M.R.C.O.G</au><au>Bhide, Priya, M.R.C.O.G</au><au>Hooper, Richard, Ph.D</au><au>Gudi, Anil, M.R.C.O.G</au><au>Shah, Amit, M.R.C.O.G</au><au>Khan, Khalid, Ph.D</au><au>Homburg, Roy, F.R.C.O.G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>107</volume><issue>6</issue><spage>1329</spage><epage>1335.e2</epage><pages>1329-1335.e2</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><abstract>Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28501361</pmid><doi>10.1016/j.fertnstert.2017.03.028</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0015-0282 |
ispartof | Fertility and sterility, 2017-06, Vol.107 (6), p.1329-1335.e2 |
issn | 0015-0282 1556-5653 |
language | eng |
recordid | cdi_proquest_miscellaneous_1899114604 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Adult Combined Modality Therapy - methods Combined Modality Therapy - utilization Comorbidity Female Fertilization in Vitro - utilization Gonadotropins - administration & dosage Humans Infertility - diagnosis Infertility - therapy Insemination, Artificial - utilization Internal Medicine intrauterine insemination In vitro fertilization Male Obstetrics and Gynecology Ovarian Hyperstimulation Syndrome - epidemiology Ovarian Hyperstimulation Syndrome - prevention & control Ovulation Induction - utilization Pregnancy Pregnancy Outcome - epidemiology Pregnancy Rate Risk Factors Treatment Outcome unexplained infertility unexplained subfertility United Kingdom - epidemiology |
title | Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intrauterine%20insemination%20with%20gonadotropin%20stimulation%20or%20in%C2%A0vitro%20fertilization%20for%20the%20treatment%20of%20unexplained%20subfertility:%20a%20randomized%20controlled%20trial&rft.jtitle=Fertility%20and%20sterility&rft.au=Nandi,%20Anupa,%20M.R.C.O.G&rft.date=2017-06-01&rft.volume=107&rft.issue=6&rft.spage=1329&rft.epage=1335.e2&rft.pages=1329-1335.e2&rft.issn=0015-0282&rft.eissn=1556-5653&rft_id=info:doi/10.1016/j.fertnstert.2017.03.028&rft_dat=%3Cproquest_cross%3E1899114604%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899114604&rft_id=info:pmid/28501361&rft_els_id=S0015028217303035&rfr_iscdi=true |